These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15257152)

  • 1. Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors.
    Miller AD; Blaha CD
    Neuroreport; 2004 Aug; 15(11):1805-8. PubMed ID: 15257152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat.
    Miller AD; Blaha CD
    Eur J Neurosci; 2005 Apr; 21(7):1837-46. PubMed ID: 15869479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat.
    Forster GL; Blaha CD
    Eur J Neurosci; 2003 Feb; 17(4):751-62. PubMed ID: 12603265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
    Miller AD; Forster GL; Yeomans JS; Blaha CD
    Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area.
    Forster GL; Blaha CD
    Eur J Neurosci; 2000 Oct; 12(10):3596-604. PubMed ID: 11029630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
    Smolders I; Bogaert L; Ebinger G; Michotte Y
    J Neurochem; 1997 May; 68(5):1942-8. PubMed ID: 9109520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
    Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats.
    Blaha CD; Winn P
    J Neurosci; 1993 Mar; 13(3):1035-44. PubMed ID: 8441002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
    Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
    Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
    Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
    J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
    Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
    Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Aceves J
    Brain Res; 1992 Dec; 598(1-2):114-20. PubMed ID: 1486473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats.
    Wang JQ; McGinty JF
    Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus.
    Chapman CA; Yeomans JS; Blaha CD; Blackburn JR
    Neuroscience; 1997 Jan; 76(1):177-86. PubMed ID: 8971770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor stimulation increases the spontaneous [3H]GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals.
    Kayadjanian N; Gioanni H; Ménetrey A; Besson MJ
    Neuroscience; 1994 Dec; 63(4):989-1002. PubMed ID: 7700520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus.
    Mathur A; Shandarin A; LaViolette SR; Parker J; Yeomans JS
    Brain Res; 1997 Nov; 775(1-2):144-55. PubMed ID: 9439838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
    Moss S; Sharott A; Goodhead LH; Mitchell SN
    Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.